MENU
+Compare
BMRN
Stock ticker: NASDAQ
AS OF
Oct 6, 04:59 PM (EDT)
Price
$55.60
Change
+$0.17 (+0.31%)
Capitalization
10.64B

BMRN BioMarin Pharmaceutical Forecast, Technical & Fundamental Analysis

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more

Industry: #Biotechnology
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMRN with price predictions
Oct 03, 2025

BMRN in upward trend: price may jump up because it broke its lower Bollinger Band on September 08, 2025

BMRN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where BMRN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 29, 2025. You may want to consider a long position or call options on BMRN as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BMRN just turned positive on September 30, 2025. Looking at past instances where BMRN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMRN advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

BMRN moved below its 50-day moving average on September 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMRN crossed bearishly below the 50-day moving average on September 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BMRN entered a downward trend on October 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.766) is normal, around the industry mean (23.241). P/E Ratio (16.351) is within average values for comparable stocks, (54.537). Projected Growth (PEG Ratio) (0.632) is also within normal values, averaging (2.239). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.527) is also within normal values, averaging (354.169).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BMRN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BMRN is expected to report earnings to fall 42.32% to 83 cents per share on October 22

BioMarin Pharmaceutical BMRN Stock Earnings Reports
Q3'25
Est.
$0.83
Q2'25
Beat
by $0.61
Q1'25
Beat
by $0.43
Q4'24
Beat
by $0.37
Q3'24
Beat
by $0.38
The last earnings report on August 04 showed earnings per share of $1.44, beating the estimate of 82 cents. With 612.00K shares outstanding, the current market capitalization sits at 10.64B.
A.I. Advisor
published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CCMG31.430.15
+0.49%
CCM Global Equity ETF
UGA62.230.27
+0.44%
United States Gasoline
RBIL50.100.01
+0.03%
F/m Ultrshrt Trs Infl-Protd Sec TIPS ETF
QIG45.44N/A
N/A
WisdomTree US Corporate Bond
MQT10.04-0.06
-0.59%
Blackrock Muni Yield Quality Fund II

BMRN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with TECH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.25%
TECH - BMRN
48%
Loosely correlated
+1.39%
SYRE - BMRN
47%
Loosely correlated
-0.56%
JAZZ - BMRN
46%
Loosely correlated
+1.65%
ROIV - BMRN
45%
Loosely correlated
+1.19%
IDYA - BMRN
45%
Loosely correlated
+1.62%
More